We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+10.28%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$5.78B
AUM Growth
+$1.86B
Cap. Flow
+$1.52B
Cap. Flow %
26.37%
Top 10 Hldgs %
27.07%
Holding
7,146
New
1,119
Increased
2,707
Reduced
2,319
Closed
677

Sector Composition

Rank Sector Weight
1 Technology 25.28%
2 Consumer Discretionary 10.53%
3 Financials 9.98%
4 Healthcare 8.97%
5 Communication Services 8.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SCWX
4476
DELISTED
SecureWorks Corp Class A Common Stock
SCWX
$11K ﹤0.01%
681
+271
+66% +$4.96K
PSTX
4477
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
$11K ﹤0.01%
1,584
-270
-15% -$1.84K
TFFP
4478
DELISTED
TFF Pharmaceuticals, Inc. Common Stock
TFFP
$11K ﹤0.01%
+52
New +$10.1K
TWKS
4479
DELISTED
Thoughtworks Holding, Inc. Common Stock
TWKS
$11K ﹤0.01%
+412
New +$11.8K
JWSM
4480
DELISTED
Jaws Mustang Acquisition Corp.
JWSM
$11K ﹤0.01%
+1,166
New +$11.4K
CVII
4481
DELISTED
Churchill Capital Corp VII Class A Common Stock
CVII
$11K ﹤0.01%
1,159
-938
-45% -$9.19K
FREE
4482
DELISTED
Whole Earth Brands, Inc. Class A Common Stock
FREE
$11K ﹤0.01%
1,070
+35
+3% +$401
DYNT
4483
DELISTED
Dynatronics Corp
DYNT
$11K ﹤0.01%
2,253
+870
+63% +$5.68K
CSSE
4484
DELISTED
Chicken Soup for the Soul Entertainment, Inc. Class A Common Stock
CSSE
$11K ﹤0.01%
828
+359
+77% +$6.21K
ALPN
4485
DELISTED
Alpine Immune Sciences Inc
ALPN
$11K ﹤0.01%
805
-1,183
-60% -$14.7K
MRNS
4486
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
$11K ﹤0.01%
954
-472
-33% -$5.45K
AFIB
4487
DELISTED
Acutus Medical Inc
AFIB
$11K ﹤0.01%
3,278
+1,549
+90% +$8.72K
SMMF
4488
DELISTED
Summit Financial Group, Inc.
SMMF
$11K ﹤0.01%
413
-460
-53% -$12.2K
RAIN
4489
DELISTED
Rain Oncology Inc. Common Stock
RAIN
$11K ﹤0.01%
919
-57
-6% -$814
ARAV
4490
DELISTED
Aravive, Inc. Common Stock
ARAV
$11K ﹤0.01%
4,908
+4,079
+492% +$13.6K
SALM
4491
DELISTED
Salem Media Group, Inc. Class A Common Stock
SALM
$11K ﹤0.01%
3,435
+1,363
+66% +$4.59K
IPVF
4492
DELISTED
InterPrivate III Financial Partners Inc.
IPVF
$11K ﹤0.01%
1,109
+793
+251% +$7.87K
TRHC
4493
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
$11K ﹤0.01%
748
-2,609
-78% -$47.5K
OFED
4494
DELISTED
Oconee Federal Financial Corp.
OFED
$11K ﹤0.01%
+506
New +$12.1K
NOVN
4495
DELISTED
Novan, Inc. Common Stock
NOVN
$11K ﹤0.01%
2,482
-5,887
-70% -$35.3K
NYMX
4496
DELISTED
Nymox Pharmaceutical Corp
NYMX
$11K ﹤0.01%
+8,417
New +$13.4K
BLU
4497
DELISTED
BELLUS Health Inc.
BLU
$11K ﹤0.01%
+1,342
New +$8.91K
BSFC
4498
DELISTED
Blue Star Foods Corp. Common Stock
BSFC
$11K ﹤0.01%
+6
New +$17.3K
ATCX
4499
DELISTED
Atlas Technical Consultants, Inc. Class A Common Stock
ATCX
$11K ﹤0.01%
1,291
-1,047
-45% -$10K
LVRA
4500
DELISTED
Levere Holdings Corp. Class A Ordinary Shares
LVRA
$11K ﹤0.01%
1,121
-274
-20% -$2.68K

Similar funds

Tower Research Capital (TRC)'s Q4 2021 Portfolio in Review

As of Q4 2021, Tower Research Capital (TRC) held 7,146 positions worth $5.78B, up 48% from $3.92B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Tower Research Capital (TRC) deployed $1.52B of net new capital in Q4 2021, opening 1,119 new positions and adding to 2,707 existing holdings. Its largest new stake was iShares Russell 1000 ETF: 47,514 shares worth $12.6M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 19% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $404M trimmed.

  • Tower Research Capital (TRC)'s largest Q4 2021 buy was iShares Russell 1000 ETF: 47,514 shares worth $12.6M.
  • Tower Research Capital (TRC) added most to Microsoft in Q4 2021, an estimated $125M increase.
  • Tower Research Capital (TRC)'s biggest Q4 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $404M.
  • Tower Research Capital (TRC) fully exited State Street SPDR S&P MIDCAP 400 ETF Trust in Q4 2021, selling an estimated $36.3M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 27% of its $5.78B portfolio in Q4 2021.
  • Tower Research Capital (TRC) opened 1,119 new positions and closed 677 in Q4 2021.
  • Tower Research Capital (TRC)'s portfolio value rose 48% quarter-over-quarter to $5.78B.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2021, filed 14 Feb 2022.